Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro

por Bowman, K J, Newell, D R, Calvert, A H, Curtin, N J
Publicado 2001

Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064.

por Bowman, K. J., White, A., Golding, B. T., Griffin, R. J., Curtin, N. J.
Publicado 1998

Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced α(1)-acid glycoprotein binding

por Curtin, N J, Bowman, K J, Turner, R N, Huang, B, Loughlin, P J, Calvert, A H, Golding, B T, Griffin, R J, Newell, D R
Publicado 1999

Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity

por Moneef, M A L, Sherwood, B T, Bowman, K J, Kockelbergh, R C, Symonds, R P, Steward, W P, Mellon, J K, Jones, G D D
Publicado 2003

Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells

por McDermott, N., Meunier, A., Mooney, B., Nortey, G., Hernandez, C., Hurley, S., Lynam-Lennon, N., Barsoom, S. H., Bowman, K. J., Marples, B., Jones, G. D. D., Marignol, L.
Publicado 2016